Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Per Dombernowsky

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Ugeskrift for Laeger|October 14, 2006
[No comments]Per Dombernowsky
Basic & Clinical Pharmacology & Toxicology|August 19, 2007
Anti-emetic therapy in cancer chemotherapy: current statusJørn Herrstedt, Per Dombernowsky
Ugeskrift for Laeger|June 27, 2002
[Sarcomas]Ole Steen Nielsen, Johnny Ø Keller, Per Dombernowsky
Breast Cancer Research and Treatment|June 14, 2005
Predictors of central nervous system metastasis in patients with metastatic breast cancer. A competing risk analysis of 579 patients treated with epirubicin-based chemotherapyMarianne Ryberg, Dorte Nielsen, Kell Osterlind, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Ugeskrift for Laeger|October 14, 2006
[No comments]Per Dombernowsky
Basic & Clinical Pharmacology & Toxicology|August 19, 2007
Anti-emetic therapy in cancer chemotherapy: current statusJørn Herrstedt, Per Dombernowsky
Ugeskrift for Laeger|June 27, 2002
[Sarcomas]Ole Steen Nielsen, Johnny Ø Keller, Per Dombernowsky
Breast Cancer Research and Treatment|June 14, 2005
Predictors of central nervous system metastasis in patients with metastatic breast cancer. A competing risk analysis of 579 patients treated with epirubicin-based chemotherapyMarianne Ryberg, Dorte Nielsen, Kell Osterlind, et al.
Pageof 1